申请人:Taisho Pharmaceutical Co. Ltd.
公开号:EP2172453A1
公开(公告)日:2010-04-07
The present invention provides compounds having excellent 11β-HSD1 inhibitory activity.
A compound represented by the following formula (I):
[wherein
X1 represents an oxygen atom, or the formula -(CR11R12)p-, etc.,
Y1 represents a hydrogen atom, a hydroxyl group, etc.,
Z1 represents an oxygen atom or the formula -(NR14)-,
R1 represents a hydrogen atom, a halogen atom, a cyano group, a C1-4 alkyl group, a C1-4 alkyl group substituted with 1 to 3 halogen atoms, a C1-4 alkoxy group, a C1-4 alkoxycarbonyl group, a carboxyl group, a carbamoyl group, or an amino group, and m represents an integer of 1 or 2, and
R2 represents a hydrogen atom or a C1-4 alkyl group, and n represents an integer of 1 or 2].
本发明提供了具有优异 11β-HSD1 抑制活性的化合物。
由下式(I)代表的化合物:
其中
X1代表氧原子,或式-(CR11R12)p-等、
Y1 代表氢原子、羟基等、
Z1 代表氧原子或式-(NR14)-、
R1 代表氢原子、卤素原子、氰基、C1-4 烷基、被 1 至 3 个卤素原子取代的 C1-4 烷基、C1-4 烷氧基、C1-4 烷氧羰基、羧基、氨基甲酰基或氨基,且 m 代表 1 或 2 的整数,且
R2 代表氢原子或 C1-4 烷基,n 代表 1 或 2 的整数]。